Arrowhead and Shire Enter into Collaboration and License Agreement to Develop Peptide-Targeted Therapeutics

[at noodls] – PASADENA, Calif. – December 18, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that it has signed a research collaboration and license agreement … more

View todays social media effects on ARWR

View the latest stocks trending across Twitter. Click to view dashboard

See who Arrowhead is hiring next, click here to view